{"transactions":[{"id":3836276,"issuer":{"id":108116,"kind":"organization","name":"Acer Therapeutics Inc.","symbol":"ACER"},"owners":[{"id":164099,"kind":"person","name":"TVM Life Science Ventures VII L.P.","position":1,"cik":"0001640880","reported_name":"TVM Life Science Ventures VII L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164100,"kind":"person","name":"Birner Hubert","position":2,"cik":"0001398598","reported_name":"Birner Hubert","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164101,"kind":"person","name":"Marengere Luc","position":3,"cik":"0001639971","reported_name":"Marengere Luc","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164102,"kind":"person","name":"Fischer Stefan","position":4,"cik":"0001398596","reported_name":"Fischer Stefan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164103,"kind":"person","name":"SCHUHSLER HELMUT","position":5,"cik":"0001133921","reported_name":"SCHUHSLER HELMUT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164104,"kind":"person","name":"Beeby Reshentha","position":6,"cik":"0001750983","reported_name":"Beeby Reshentha","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164105,"kind":"person","name":"Leatt Gary","position":7,"cik":"0001718117","reported_name":"Leatt Gary","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-22T16:22:11.000Z","date":"2018-08-01","kind":"purchase","acquired":true,"shares":275000,"price":18,"value":4950000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are directly held by TVM Life Science Ventures VII L.P. (\"TVM VII LP\"). TVM Life Science Ventures VII (GP) Ltd. (\"TVM VII GP Ltd\") is the general partner of TVM VII LP. Hubert Birner (\"Birner\"), Stefan Fischer (\"Fischer\"), Helmut Schuhsler (\"Schuhsler\"), Luc Marengere (\"Marengere\"), Reshentha Beeby (\"Beeby\"), and Gary Leatt (\"Leatt\") are members of the investment committee of TVM VII GP Ltd, which has voting and investment power with respect to these shares. TVM VII GP Ltd, Birner, Fischer, Schuhsler, Marengere, Beeby and Leatt each disclaim any beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein, if any. Marengere is a director of the Issuer."}],"balance_after":1697709,"source":{"system":"sec-edgar","filing":"0001012975-18-001040","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069308/000101297518001040/edgar.xml","form_type":"4"}},{"id":4100692,"issuer":{"id":108116,"kind":"organization","name":"Acer Therapeutics Inc.","symbol":"ACER"},"owners":[{"id":170324,"kind":"person","name":"TVM Life Science Ventures VI GmbH & Co KG","position":1,"cik":"0001599744","reported_name":"TVM Life Science Ventures VI GmbH & Co KG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":170325,"kind":"person","name":"TVM Life Science Ventures VI LP","position":2,"cik":"0001318584","reported_name":"TVM Life Science Ventures VI LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164099,"kind":"person","name":"TVM Life Science Ventures VII L.P.","position":3,"cik":"0001640880","reported_name":"TVM Life Science Ventures VII L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164100,"kind":"person","name":"Birner Hubert","position":4,"cik":"0001398598","reported_name":"Birner Hubert","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164101,"kind":"person","name":"Marengere Luc","position":5,"cik":"0001639971","reported_name":"Marengere Luc","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164102,"kind":"person","name":"Fischer Stefan","position":6,"cik":"0001398596","reported_name":"Fischer Stefan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164103,"kind":"person","name":"SCHUHSLER HELMUT","position":7,"cik":"0001133921","reported_name":"SCHUHSLER HELMUT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":170326,"kind":"person","name":"Wanless Mark","position":8,"cik":"0001718086","reported_name":"Wanless Mark","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164105,"kind":"person","name":"Leatt Gary","position":9,"cik":"0001718117","reported_name":"Leatt Gary","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-12T14:33:26.000Z","date":"2017-12-12","kind":"purchase","acquired":true,"shares":250000,"price":12,"value":3000000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are directly held by TVM Life Science Ventures VII L.P. (\"TVM VII LP\"). TVM Life Science Ventures VII (GP) Ltd. (\"TVM VII GP Ltd\") is the general partner of TVM VII LP. Luc Marengere (\"Marengere\"), Mark Wanless (\"Wanless\"), Gary Leatt (\"Leatt\"), Birner, Fischer and Schuhsler are members of the investment committee of TVM VII GP Ltd, which has voting and investment power with respect to these shares. TVM VII GP Ltd, Birner, Fischer, Schuhsler, Marengere, Wanless and Leatt each disclaim any beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein, if any. Marengere is a director of the Issuer."}],"balance_after":1422709,"source":{"system":"sec-edgar","filing":"0001012975-18-000059","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069308/000101297518000059/edgar.xml","form_type":"4"}},{"id":4100691,"issuer":{"id":108116,"kind":"organization","name":"Acer Therapeutics Inc.","symbol":"ACER"},"owners":[{"id":170324,"kind":"person","name":"TVM Life Science Ventures VI GmbH & Co KG","position":1,"cik":"0001599744","reported_name":"TVM Life Science Ventures VI GmbH & Co KG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":170325,"kind":"person","name":"TVM Life Science Ventures VI LP","position":2,"cik":"0001318584","reported_name":"TVM Life Science Ventures VI LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164099,"kind":"person","name":"TVM Life Science Ventures VII L.P.","position":3,"cik":"0001640880","reported_name":"TVM Life Science Ventures VII L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164100,"kind":"person","name":"Birner Hubert","position":4,"cik":"0001398598","reported_name":"Birner Hubert","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164101,"kind":"person","name":"Marengere Luc","position":5,"cik":"0001639971","reported_name":"Marengere Luc","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164102,"kind":"person","name":"Fischer Stefan","position":6,"cik":"0001398596","reported_name":"Fischer Stefan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164103,"kind":"person","name":"SCHUHSLER HELMUT","position":7,"cik":"0001133921","reported_name":"SCHUHSLER HELMUT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":170326,"kind":"person","name":"Wanless Mark","position":8,"cik":"0001718086","reported_name":"Wanless Mark","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164105,"kind":"person","name":"Leatt Gary","position":9,"cik":"0001718117","reported_name":"Leatt Gary","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-12T14:33:26.000Z","date":"2017-12-12","kind":"purchase","acquired":true,"shares":21271,"price":12,"value":255252.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by TVM Life Science Ventures VI L.P. (\"TVM VI LP\"). Birner, Schuhsler and Fischer are members of the investment committee of TVM VI Management, a special limited partner of TVM VI LP, with voting and dispositive power over the shares held by TVM VI LP. TVM VI Management, Birner, Schuhsler and Fischer each disclaim beneficial ownership of the shares held by TVM VI LP, except to the extent of any pecuniary interest therein, if any."}],"balance_after":248756,"source":{"system":"sec-edgar","filing":"0001012975-18-000059","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069308/000101297518000059/edgar.xml","form_type":"4"}},{"id":4100690,"issuer":{"id":108116,"kind":"organization","name":"Acer Therapeutics Inc.","symbol":"ACER"},"owners":[{"id":170324,"kind":"person","name":"TVM Life Science Ventures VI GmbH & Co KG","position":1,"cik":"0001599744","reported_name":"TVM Life Science Ventures VI GmbH & Co KG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":170325,"kind":"person","name":"TVM Life Science Ventures VI LP","position":2,"cik":"0001318584","reported_name":"TVM Life Science Ventures VI LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164099,"kind":"person","name":"TVM Life Science Ventures VII L.P.","position":3,"cik":"0001640880","reported_name":"TVM Life Science Ventures VII L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164100,"kind":"person","name":"Birner Hubert","position":4,"cik":"0001398598","reported_name":"Birner Hubert","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164101,"kind":"person","name":"Marengere Luc","position":5,"cik":"0001639971","reported_name":"Marengere Luc","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164102,"kind":"person","name":"Fischer Stefan","position":6,"cik":"0001398596","reported_name":"Fischer Stefan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164103,"kind":"person","name":"SCHUHSLER HELMUT","position":7,"cik":"0001133921","reported_name":"SCHUHSLER HELMUT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":170326,"kind":"person","name":"Wanless Mark","position":8,"cik":"0001718086","reported_name":"Wanless Mark","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164105,"kind":"person","name":"Leatt Gary","position":9,"cik":"0001718117","reported_name":"Leatt Gary","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-12T14:33:26.000Z","date":"2017-12-12","kind":"purchase","acquired":true,"shares":62062,"price":12,"value":744744.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by TVM Life Science Ventures VI GmbH & Co. KG (\"TVM VI\"). Hubert Birner (\"Birner\"), Stefan Fischer (\"Fischer\"), and Helmut Schuhsler (\"Schuhsler\") are members of the investment committee of TVM Life Science Ventures Management VI L.P. (\"TVM VI Management\"), a special limited partner of TVM VI, with voting and dispositive power over the shares held by TVM VI. TVM VI Management, Birner, Schuhsler and Fischer each disclaim beneficial ownership of the shares held by TVM VI, except to the extent of any pecuniary interest therein, if any. Birner is a director of the Issuer."}],"balance_after":725844,"source":{"system":"sec-edgar","filing":"0001012975-18-000059","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069308/000101297518000059/edgar.xml","form_type":"4"}},{"id":4201071,"issuer":{"id":108116,"kind":"organization","name":"Acer Therapeutics Inc.","symbol":"ACER"},"owners":[{"id":170324,"kind":"person","name":"TVM Life Science Ventures VI GmbH & Co KG","position":1,"cik":"0001599744","reported_name":"TVM Life Science Ventures VI GmbH & Co KG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":170325,"kind":"person","name":"TVM Life Science Ventures VI LP","position":2,"cik":"0001318584","reported_name":"TVM Life Science Ventures VI LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164099,"kind":"person","name":"TVM Life Science Ventures VII L.P.","position":3,"cik":"0001640880","reported_name":"TVM Life Science Ventures VII L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164100,"kind":"person","name":"Birner Hubert","position":4,"cik":"0001398598","reported_name":"Birner Hubert","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164101,"kind":"person","name":"Marengere Luc","position":5,"cik":"0001639971","reported_name":"Marengere Luc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164102,"kind":"person","name":"Fischer Stefan","position":6,"cik":"0001398596","reported_name":"Fischer Stefan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164103,"kind":"person","name":"SCHUHSLER HELMUT","position":7,"cik":"0001133921","reported_name":"SCHUHSLER HELMUT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":170326,"kind":"person","name":"Wanless Mark","position":8,"cik":"0001718086","reported_name":"Wanless Mark","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164105,"kind":"person","name":"Leatt Gary","position":9,"cik":"0001718117","reported_name":"Leatt Gary","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-27T18:34:28.000Z","date":"2017-09-19","kind":"other","acquired":true,"shares":1172709,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired pursuant to an Agreement and Plan of Merger, dated as of June 30, 2017 (the \"Merger Agreement\"), pursuant to which a wholly-owned subsidiary of the Issuer merged with and into Acer Therapeutics Inc. (\"Acer\"). Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement) of the closing of the Mergers contemplated thereby, the then outstanding shares of Acer's common stock were cancelled and were automatically converted into the right to receive 1 share of the Issuer's common stock for each share of Acer common stock then held by the Reporting Persons. These shares were previously reported on a Form 3 filed by the Reporting Persons on the date of this filing."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were acquired pursuant to an Agreement and Plan of Merger, dated as of June 30, 2017 (the \"Merger Agreement\"), pursuant to which a wholly-owned subsidiary of the Issuer merged with and into Acer Therapeutics Inc. (\"Acer\"). Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement) of the closing of the Mergers contemplated thereby, the then outstanding shares of Acer's common stock were cancelled and were automatically converted into the right to receive 1 share of the Issuer's common stock for each share of Acer common stock then held by the Reporting Persons. These shares were previously reported on a Form 3 filed by the Reporting Persons on the date of this filing."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are directly held by TVM Life Science Ventures VII L.P. (\"TVM VII LP\"). TVM Life Science Ventures VII (GP) Ltd. (\"TVM VII GP Ltd\") is the general partner of TVM VII LP. Luc Marengere (\"Marengere\"), Mark Wanless (\"Wanless\"), Gary Leatt (\"Leatt\"), Birner, Fischer and Schuhsler are members of the investment committee of TVM VII GP Ltd, which has voting and investment power with respect to these shares. TVM VII GP Ltd, Birner, Fischer, Schuhsler, Marengere, Wanless and Leatt each disclaim any beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein, if any. Marengere is a director of the Issuer."}],"balance_after":1172709,"source":{"system":"sec-edgar","filing":"0001012975-17-000726","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069308/000101297517000726/edgar.xml","form_type":"4"}},{"id":4201070,"issuer":{"id":108116,"kind":"organization","name":"Acer Therapeutics Inc.","symbol":"ACER"},"owners":[{"id":170324,"kind":"person","name":"TVM Life Science Ventures VI GmbH & Co KG","position":1,"cik":"0001599744","reported_name":"TVM Life Science Ventures VI GmbH & Co KG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":170325,"kind":"person","name":"TVM Life Science Ventures VI LP","position":2,"cik":"0001318584","reported_name":"TVM Life Science Ventures VI LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164099,"kind":"person","name":"TVM Life Science Ventures VII L.P.","position":3,"cik":"0001640880","reported_name":"TVM Life Science Ventures VII L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164100,"kind":"person","name":"Birner Hubert","position":4,"cik":"0001398598","reported_name":"Birner Hubert","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164101,"kind":"person","name":"Marengere Luc","position":5,"cik":"0001639971","reported_name":"Marengere Luc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164102,"kind":"person","name":"Fischer Stefan","position":6,"cik":"0001398596","reported_name":"Fischer Stefan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164103,"kind":"person","name":"SCHUHSLER HELMUT","position":7,"cik":"0001133921","reported_name":"SCHUHSLER HELMUT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":170326,"kind":"person","name":"Wanless Mark","position":8,"cik":"0001718086","reported_name":"Wanless Mark","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164105,"kind":"person","name":"Leatt Gary","position":9,"cik":"0001718117","reported_name":"Leatt Gary","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-27T18:34:28.000Z","date":"2017-09-19","kind":"other","acquired":true,"shares":227485,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired pursuant to an Agreement and Plan of Merger, dated as of June 30, 2017 (the \"Merger Agreement\"), pursuant to which a wholly-owned subsidiary of the Issuer merged with and into Acer Therapeutics Inc. (\"Acer\"). Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement) of the closing of the Mergers contemplated thereby, the then outstanding shares of Acer's common stock were cancelled and were automatically converted into the right to receive 1 share of the Issuer's common stock for each share of Acer common stock then held by the Reporting Persons. These shares were previously reported on a Form 3 filed by the Reporting Persons on the date of this filing."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were acquired pursuant to an Agreement and Plan of Merger, dated as of June 30, 2017 (the \"Merger Agreement\"), pursuant to which a wholly-owned subsidiary of the Issuer merged with and into Acer Therapeutics Inc. (\"Acer\"). Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement) of the closing of the Mergers contemplated thereby, the then outstanding shares of Acer's common stock were cancelled and were automatically converted into the right to receive 1 share of the Issuer's common stock for each share of Acer common stock then held by the Reporting Persons. These shares were previously reported on a Form 3 filed by the Reporting Persons on the date of this filing."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are directly held by TVM Life Science Ventures VI L.P. (\"TVM VI LP\"). Birner, Schuhsler and Fischer are members of the investment committee of TVM VI Management, a special limited partner of TVM VI LP, with voting and dispositive power over the shares held by TVM VI LP. TVM VI Management, Birner, Schuhsler and Fischer each disclaim beneficial ownership of the shares held by TVM VI LP, except to the extent of any pecuniary interest therein, if any."}],"balance_after":227485,"source":{"system":"sec-edgar","filing":"0001012975-17-000726","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069308/000101297517000726/edgar.xml","form_type":"4"}},{"id":4201069,"issuer":{"id":108116,"kind":"organization","name":"Acer Therapeutics Inc.","symbol":"ACER"},"owners":[{"id":170324,"kind":"person","name":"TVM Life Science Ventures VI GmbH & Co KG","position":1,"cik":"0001599744","reported_name":"TVM Life Science Ventures VI GmbH & Co KG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":170325,"kind":"person","name":"TVM Life Science Ventures VI LP","position":2,"cik":"0001318584","reported_name":"TVM Life Science Ventures VI LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164099,"kind":"person","name":"TVM Life Science Ventures VII L.P.","position":3,"cik":"0001640880","reported_name":"TVM Life Science Ventures VII L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164100,"kind":"person","name":"Birner Hubert","position":4,"cik":"0001398598","reported_name":"Birner Hubert","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164101,"kind":"person","name":"Marengere Luc","position":5,"cik":"0001639971","reported_name":"Marengere Luc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164102,"kind":"person","name":"Fischer Stefan","position":6,"cik":"0001398596","reported_name":"Fischer Stefan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164103,"kind":"person","name":"SCHUHSLER HELMUT","position":7,"cik":"0001133921","reported_name":"SCHUHSLER HELMUT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":170326,"kind":"person","name":"Wanless Mark","position":8,"cik":"0001718086","reported_name":"Wanless Mark","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164105,"kind":"person","name":"Leatt Gary","position":9,"cik":"0001718117","reported_name":"Leatt Gary","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-27T18:34:28.000Z","date":"2017-09-19","kind":"other","acquired":true,"shares":663782,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired pursuant to an Agreement and Plan of Merger, dated as of June 30, 2017 (the \"Merger Agreement\"), pursuant to which a wholly-owned subsidiary of the Issuer merged with and into Acer Therapeutics Inc. (\"Acer\"). Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement) of the closing of the Mergers contemplated thereby, the then outstanding shares of Acer's common stock were cancelled and were automatically converted into the right to receive 1 share of the Issuer's common stock for each share of Acer common stock then held by the Reporting Persons. These shares were previously reported on a Form 3 filed by the Reporting Persons on the date of this filing."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were acquired pursuant to an Agreement and Plan of Merger, dated as of June 30, 2017 (the \"Merger Agreement\"), pursuant to which a wholly-owned subsidiary of the Issuer merged with and into Acer Therapeutics Inc. (\"Acer\"). Pursuant to the Merger Agreement, at the Effective Time (as defined in the Merger Agreement) of the closing of the Mergers contemplated thereby, the then outstanding shares of Acer's common stock were cancelled and were automatically converted into the right to receive 1 share of the Issuer's common stock for each share of Acer common stock then held by the Reporting Persons. These shares were previously reported on a Form 3 filed by the Reporting Persons on the date of this filing."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by TVM Life Science Ventures VI GmbH & Co. KG (\"TVM VI\"). Hubert Birner (\"Birner\"), Stefan Fischer (\"Fischer\"), and Helmut Schuhsler (\"Schuhsler\") are members of the investment committee of TVM Life Science Ventures Management VI L.P. (\"TVM VI Management\"), a special limited partner of TVM VI, with voting and dispositive power over the shares held by TVM VI. TVM VI Management, Birner, Schuhsler and Fischer each disclaim beneficial ownership of the shares held by TVM VI, except to the extent of any pecuniary interest therein, if any. Birner is a director of the Issuer."}],"balance_after":663782,"source":{"system":"sec-edgar","filing":"0001012975-17-000726","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069308/000101297517000726/edgar.xml","form_type":"4"}},{"id":4269457,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":170324,"kind":"person","name":"TVM Life Science Ventures VI GmbH & Co KG","position":1,"cik":"0001599744","reported_name":"TVM Life Science Ventures VI GmbH & Co KG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":170325,"kind":"person","name":"TVM Life Science Ventures VI LP","position":2,"cik":"0001318584","reported_name":"TVM Life Science Ventures VI LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164100,"kind":"person","name":"Birner Hubert","position":3,"cik":"0001398598","reported_name":"Birner Hubert","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164102,"kind":"person","name":"Fischer Stefan","position":4,"cik":"0001398596","reported_name":"Fischer Stefan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164103,"kind":"person","name":"SCHUHSLER HELMUT","position":5,"cik":"0001133921","reported_name":"SCHUHSLER HELMUT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2017-06-30T13:51:25.000Z","date":"2017-06-22","kind":"purchase","acquired":true,"shares":372,"price":1000,"value":372000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This amendment to the original Form 4 does not amend any item originally reported in Table II and the first line item of Table II is restated in this amendment for the sole purpose of gaining access to the electronic filing system; footnotes relating to such first line item are included for completeness and have not been amended.  This amendment is made by the Reporting Persons solely to include the power of attorney attached hereto as Exhibit 24."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares are directly held by TVM Life Science Ventures VI GMBH & Co. KG (\"TVM VI\").  Hubert Birner (\"Birner\"), Stefan Fischer (\"Fischer\"), and Helmut Schuhsler (\"Schuhsler\") are members of the investment committee of TVM Life Science Management VI L.P. (\"TVM VI Management\"), a special limited partner of TVM VI, with voting and dispositive power over the shares held by TVM VI.  TVM VI Management, Birner, Schuhsler and Fischer each disclaim beneficial ownership of the shares held by TVM VI, except to the extent of any pecuniary interest therein, if any.  Birner is a director of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series A convertible preferred stock (the \"Series A Stock\") is convertible, at the option of the holder, into Proteon Therapeutics Inc. common stock, $0.01 par value per share (the \"Common Stock\"), at a price per share equal to $0.9949."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series A Stock has no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"The certificate of designations for the Series A Stock contains a provision prohibiting conversion to the extent that upon conversion the holder, together with its affiliates and any \"group\" members, would beneficially own in excess of 9.985% of the number of shares of Common Stock then outstanding."}],"balance_after":500,"derivative":{"exercise_price":0.9949,"underlying":"Common Stock, $0.001 par value","underlying_shares":373907},"source":{"system":"sec-edgar","filing":"0001012975-17-000502","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133921/000101297517000502/edgar.xml","form_type":"4/A","original_submission_date":"2017-06-26"}},{"id":4272646,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":170324,"kind":"person","name":"TVM Life Science Ventures VI GmbH & Co KG","position":1,"cik":"0001599744","reported_name":"TVM Life Science Ventures VI GmbH & Co KG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":170325,"kind":"person","name":"TVM Life Science Ventures VI LP","position":2,"cik":"0001318584","reported_name":"TVM Life Science Ventures VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164100,"kind":"person","name":"Birner Hubert","position":3,"cik":"0001398598","reported_name":"Birner Hubert","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164102,"kind":"person","name":"Fischer Stefan","position":4,"cik":"0001398596","reported_name":"Fischer Stefan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164103,"kind":"person","name":"SCHUHSLER HELMUT","position":5,"cik":"0001133921","reported_name":"SCHUHSLER HELMUT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2017-06-26T18:06:38.000Z","date":"2017-06-22","kind":"purchase","acquired":true,"shares":128,"price":1000,"value":128000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"The shares are directly held by TVM Life Science Ventures VI L.P. (\"TVM VI LP\"). Birner, Fischer and Schuhsler are members of the investment committee of TVM VI Management, a special limited partner of TVM VI LP, with voting and dispositive power over the shares held by TVM VI LP. TVM VI Management, Birner, Fischer and Schuhsler each disclaim beneficial ownership of the shares held by TVM VI LP, except to the extent of any pecuniary interest therein, if any."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series A convertible preferred stock (the \"Series A Stock\") is convertible, at the option of the holder, into Proteon Therapeutics Inc. common stock, $0.001 par value per share (the \"Common Stock\"), at a price per share equal to $0.9949."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series A Stock has no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"The certificate of designations for the Series A Stock contains a provision prohibiting conversion to the extent that upon conversion the holder, together with its affiliates and any \"group\" members, would beneficially own in excess of 9.985% of the number of shares of Common Stock then outstanding."}],"balance_after":500,"derivative":{"exercise_price":0.9949,"underlying":"Common Stock, $0.001 par value","underlying_shares":128656},"source":{"system":"sec-edgar","filing":"0000899243-17-017250","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133921/000089924317017250/doc4.xml","form_type":"4"}},{"id":4272645,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":170324,"kind":"person","name":"TVM Life Science Ventures VI GmbH & Co KG","position":1,"cik":"0001599744","reported_name":"TVM Life Science Ventures VI GmbH & Co KG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":170325,"kind":"person","name":"TVM Life Science Ventures VI LP","position":2,"cik":"0001318584","reported_name":"TVM Life Science Ventures VI LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164100,"kind":"person","name":"Birner Hubert","position":3,"cik":"0001398598","reported_name":"Birner Hubert","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164102,"kind":"person","name":"Fischer Stefan","position":4,"cik":"0001398596","reported_name":"Fischer Stefan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164103,"kind":"person","name":"SCHUHSLER HELMUT","position":5,"cik":"0001133921","reported_name":"SCHUHSLER HELMUT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2017-06-26T18:06:38.000Z","date":"2017-06-22","kind":"purchase","acquired":true,"shares":372,"price":1000,"value":372000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares are directly held by TVM Life Science Ventures VI GMBH & Co. KG (\"TVM VI\"). Hubert Birner (\"Birner\"), Stefan Fischer (\"Fischer\"), and Helmut Schuhsler (\"Schuhsler\") are members of the investment committee of TVM Life Science Ventures Management VI L.P. (\"TVM VI Management\"), a special limited partner of TVM VI, with voting and dispositive power over the shares held by TVM VI. TVM VI Management, Birner, Schuhsler and Fischer each disclaim beneficial ownership of the shares held by TVM VI, except to the extent of any pecuniary interest therein, if any.  Birner is a director of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series A convertible preferred stock (the \"Series A Stock\") is convertible, at the option of the holder, into Proteon Therapeutics Inc. common stock, $0.001 par value per share (the \"Common Stock\"), at a price per share equal to $0.9949."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series A Stock has no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"The certificate of designations for the Series A Stock contains a provision prohibiting conversion to the extent that upon conversion the holder, together with its affiliates and any \"group\" members, would beneficially own in excess of 9.985% of the number of shares of Common Stock then outstanding."}],"balance_after":500,"derivative":{"exercise_price":0.9949,"underlying":"Common Stock, $0.001 par value","underlying_shares":373907},"source":{"system":"sec-edgar","filing":"0000899243-17-017250","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133921/000089924317017250/doc4.xml","form_type":"4"}}]}